BD simplifies at-home HPV testing to expand access to cervical cancer screening outside the United States

FRANKLIN LAKES, NJ, Oct 22, 2025 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a new self-collection solution for HPV testing in markets outside the United States. This new innovation simplifies home sample collection for patients and further automates laboratory processing using high-tech robotics with the BD COR™ System.

The new swab technology has been certified by the In Vitro Diagnostic Devices (IVDR) Regulation in Europe, which is also recognized by many other countries around the world. The new self-collection technology offers patients a safe, simple and non-invasive collection experience without the need for fluids or complex equipment. The stability of the swab also allows for convenient shipping from home to the laboratory, helping to eliminate logistical hurdles and supporting broader participation in cervical cancer screening programs.

In the laboratory, self-collected swab does not require manual sample preparation by clinical laboratory technicians, allowing them to focus on more important tasks. Once the sample is placed into the BD COR™ system, the preparation, analysis and reporting of results for each sample occurs in a fully automated process using sophisticated robotics. The use of internal cellular control combined with minimal manual intervention and intervention helps ensure sample integrity from collection to delivery of reliable, high-quality results.

“This certification represents a significant step forward in our efforts to expand access to cervical cancer screening worldwide,” said Nikos Pavlidis, global president of BD Diagnostic Solutions. “By enabling fully automated processing of self-collected samples, we are helping laboratories increase their efficiency while making it easier for under-screened individuals to participate in screening programs from the comfort of their own home.”

Key features of the IVDR certified workflow include:

• Integrated rehydration technology that eliminates the need for manual sample preparation
• Safe, dry self-collection without liquids or chemicals
• Simple, user-friendly process for patients with easy shipping
• 30 days dry sample stability, including up to 5 days at 45°C and 4 freeze/thaw cycles
• Unified, barcode-driven workflow for both clinician-collected and self-collected samples
• Proven performance of the Copan FLOQSwab®

BD Onclarity™ HPV Self-Collection with Integrated Rehydration, a fully automated solution, is expected to be commercially available in all IVDR-approved markets in the coming months, supporting public health efforts to expand access to cervical cancer screening while improving laboratory efficiency.

To find out more, visit https://eu.bd.com/cervical-screening-solutions/en/

About BD
BD is one of the world's largest global medical technology companies, advancing the world of health by improving medical research, diagnostics and care. The company supports the heroes on the front lines of healthcare by developing innovative technologies, services and solutions that help advance both clinical therapy for patients and the clinical process for healthcare providers. BD and its more than 70,000 employees are passionate and committed to improving the safety and efficiency of the physician care process, enabling laboratory scientists to accurately detect disease, and enhancing the ability of researchers to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and works with organizations around the world to address some of the most challenging global health issues. By working closely with customers, BD can help improve outcomes, reduce costs, increase efficiency, improve safety and expand access to healthcare. For more information about BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson

SOURCE BD (Becton, Dickinson and Company)